Lifeboat Foundation

There are many components that make The Orville: New Horizons a great show, and not the least of which are the beautiful visuals. Please enjoy this compilation of amazing shots from the final four episodes of the third season of The Orville.

Part 1: https://youtu.be/EkuP4rQC-Zc.

Continue reading “The Amazing Visuals of The Orville: New Horizons (Part 2 of 2)” »

Father son duo Jim and Andrew Kazmer build and drive one of the most exciting and best supported robots at NHRL in Project Liftoff.

They’ve further developed this into a second bot in Flip n Cut with a variation in weapon type and have pushed the limits of innovation with their fully autonomous combat robot DeepMelt.

Continue reading “Project Liftoff: The Future Of Robot Combat is AI. This Is Havoc Episode 4” »

The last event of 2022 will take place December 19th: Christmas Special meeting. with our president Prof. Bernard Foing!
We’ll have a look at what we have done in 2022, and we’ll announce the program of 2023.
The Zoom meeting will be open to all of the SRI Members and invited friends – just registered or going to register during the meeting.
All the participants will have the possibility to make questions to the SRI President, the Founder and the Board of Directors, about the 2023 program. Criticisms and proposals will be welcome too.
We have a huge programme for 2023, and we are going through some key steps, to achieve an higher legal status for our association: to be registered as a not for profit entity on the Unic National Register of the Third Sector Entities (RUNTS). Such an achievement will allow SRI to call Italian taxpayers to target the 5×1000 of their yearly tax to SRI, and the donations to be deducted from the tax declaration. These conditions, when achieved, will greatly contribute to the sustainability of our initiatives.
We are asking each of the SRI members and supporters to assume this priority for December 2022: to bring onboard many new members and to seek for donors and sponsors!
We will celebrate together during the Xmas Special event and exchange season greetings and wishes for a vibrant year 2023 for Space Renaissance International!

Until now, some researchers believed Langerhans cell histiocytosis (LCH), a rare and fatal form of cancer in children, is derived from immune cells called dendritic cells, while others believed that they originate from related immune cells called monocytes. A new study showed mutated LCH cells have properties similar to both monocytes and dendritic cells, as well as a relatively new type of dendritic cell called DC3.

Start listening with a 30-day Audible trial and your first audiobook plus two Audible Originals are free. Visit.
http://www.audible.com/isaac or text “ISAAC” to 500–500.
The Fermi Paradox ask us how in a Universe so vast and ancient we seem to be the only intelligent civilization around, with no older interstellar alien empires visible in the galaxy. But could extinction play a role in that, or might extinction events instead drive evolution forward?

Visit our Website: http://www.isaacarthur.net.
Support us on Patreon: https://www.patreon.com/IsaacArthur.
SFIA Merchandise available: https://www.signil.com/sfia/

Continue reading “The Fermi Paradox: Extinction” »

MONDAY, Dec. 19, 2022 (HealthDay News) — Patients with a high-risk bladder cancer now have a new option to treat it.

The U.S. Food and Drug Administration on Friday approved a gene therapy called Adstiladrin, which is designed to work for patients who have what’s called high-risk non-muscle-invasive bladder cancer (NMIBC) that hasn’t responded to the standard treatment, Bacillus Calmette-Guérin (BCG), but hasn’t spread. BCG is a vaccine typically used for tuberculosis.

“This approval provides health care professionals with an innovative treatment option for patients with high-risk NMIBC that is unresponsive to BCG therapy,” Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said in an agency news release. “Today’s action addresses an area of critical need. The FDA remains committed to facilitating the development and approval of safe and effective cancer treatments.”

Dec. 14, 2021 — A new FDA-approved eyedrop medicine could replace reading glasses for millions of Americans who have age-related blurry vision.

The product, called Vuity, was approved by the FDA in October and went on the market last week. The new medicine begins working in about 15 minutes and provides sharper vision for 6 to 10 hours.

Vuity is the first FDA-approved eyedrop to treat the condition known as presbyopia, which tends to affect people ages 40 and older. The prescription drug uses the eye’s natural ability to reduce its pupil size.

A new chip re-creates the human vagina’s unique microbiome.

Around 38% of the world’s total landmass is used for agriculture – yet hunger is worsening, and food security is in crisis, threatened by pressures including climate change, conflict and global recessions.

While there’s no one-stop solution, technology can help to fill some of the gaps. Mechanical engineer Josie Hughes is on a mission to show how robotics can play a role in our everyday lives, particularly when it comes to food. Starting with LEGO robots as a child, the Cambridge graduate now leads the Computational Robot Design & Fabrication Lab (CREATE) at the Swiss Federal Institute of Technology Lausanne (EPFL), where she’s one of the youngest researchers to join as a tenure-track assistant professor.

One of her innovations, a raspberry-picking robot powered by artificial intelligence, could help make farming more efficient and cost-effective, and solve labor shortages – which in the UK alone left £60 million ($74 million) worth of fruit and vegetables rotting in fields this summer. CNN spoke with Hughes about her research, and when robots might be harvesting your next meal.